Pierce Eggan

Customizable virus-like particles deliver CRISPR–Cas9 ribonucleoprotein for effective ocular neovascular and Huntington’s disease gene therapy

Microbiota–neuroepithelial signalling across the gut–brain axis

C9orf72 suppresses systemic and neural inflammation induced by gut bacteria

Herpesviral lytic gene functions render the viral genome susceptible to novel editing by CRISPR/Cas9